Great Place To Work® and Fortune Name Chiesi Group No. 23in 2024 World’s Best Workplaces™ List
Pharmafile
NOVEMBER 19, 2024
23in 2024 World’s Best Workplaces™ List appeared first on Pharmafile.
Open Source “Wikipedia” for Drug Discovery
Pharma Mirror
OCTOBER 4, 2021
Despite untold investment by numerous pharmaceutical companies, FDA-approved drugs that target critical brain functions and conditions like anxiety, depression, and sedation continue to present severe and unpredictable side effects, including suicidal ideation. In 2003 the Human Genome Project provided the first atlas.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Magazine: Pharma’s green shift with dry powder inhalers
Pharmaceutical Technology
NOVEMBER 22, 2024
Several pharmaceutical companies are advancing dry powder inhalers (DPIs) for respiratory conditions in an effort to cut down on greenhouse emissions and create a solution that is more eco-friendly than traditional pressurised metered-dose inhalers (pMDIs).
Rashedi Hassan takes over Sales & Marketing management of Telstar’s subsidiary in Bangladesh
Pharma Mirror
MAY 19, 2021
The post Rashedi Hassan takes over Sales & Marketing management of Telstar’s subsidiary in Bangladesh appeared first on Pharma Mirror Magazine. Rashedi Hassan holds a Diploma in Engineering from Dhaka Polytechnic Institute. With more than 18.
Healthware Group appoints Eugene Borukhovich as senior advisor
pharmaphorum
OCTOBER 15, 2021
Prior to that, Eugene held pharmacy benefit management, consulting and pharmaceutical company leadership roles, with his most recent role being at Bayer where he led a global digital health team investing, partnering and building ventures.
Responding to dynamic shifts in value communications
pharmaphorum
OCTOBER 7, 2020
OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies. Value in healthcare is a continually changing concept. The post Responding to dynamic shifts in value communications appeared first on.
A new dawn for clinical trial management
pharmaphorum
NOVEMBER 9, 2020
Now, the major advance that’s available to pharmaceutical companies is in the amount and range of data they have access to and how it can be applied to the risk-based monitoring and remote monitoring of studies. • Read the full article in pharmaphorum’s Deep Dive digital magazine.
Enabling new models of care: pursuing pharma’s partnership potential
pharmaphorum
JANUARY 15, 2021
As new approaches to healthcare attainment take hold there will be some degree of uncertainty among pharmaceutical companies about where they fit into the new structures and the holistic care they seek to provide. The post Enabling new models of care: pursuing pharma’s partnership potential appeared first on.
Dr. August Wolff and Cantabria Labs enter into an exclusive commercialization agreement for Southern Europe for hyperhidrosis product
Pharma Mirror
APRIL 13, 2021
The German pharmaceutical company Dr. August Wolff GmbH & Co. Wolff”) and the Spanish pharmaceutical company Cantabria Labs (“Cantabria Labs”) concluded a strategic partnership on March 12th 2021 by entering into an exclusive licensing agreement for a newly developed medicinal product for the treatment of hyperhidrosis.
Germany’s digital health changes will boost digital therapeutics in Europe
pharmaphorum
NOVEMBER 10, 2020
The post Germany’s digital health changes will boost digital therapeutics in Europe appeared first on.
Tailor-made Solution for Collagenase
Pharma Mirror
JUNE 11, 2024
With 650 employees, Nordmark Pharma, based in Uetersen, Germany, is not one of the world’s largest pharmaceutical companies. Nevertheless, the owner-run, The post Tailor-made Solution for Collagenase appeared first on Pharma Mirror Magazine.
Deep Dive: Digital Health 2021
pharmaphorum
DECEMBER 17, 2021
pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector. Read Deep Dive: Digital Health in full. Subscribe to future issues of Deep Dive.
Neuraxpharm completes its presence in Benelux
Pharma Mirror
JANUARY 24, 2023
Neuraxpharm Belgium will be based in Brussels and will distribute and market prescription brand The post Neuraxpharm completes its presence in Benelux appeared first on Pharma Mirror Magazine.
InSilicoTrials releases two new state-of-the-art simulation tools for oncology
Pharma Mirror
OCTOBER 15, 2021
Milan, InSilicoTrials has been innovating the healthcare sector for some years now, helping pharmaceutical companies reduce the time and cost of drug development using modeling & simulation. The post InSilicoTrials releases two new state-of-the-art simulation tools for oncology appeared first on Pharma Mirror Magazine.
Provepharm Life Solutions raises €120 million
Pharma Mirror
SEPTEMBER 8, 2021
Marseille, France, Provepharm Life Solutions, a private French pharmaceutical company that finds new applications for well-known molecules, today announces a €120 million ($142.3M) strategic funding. The post Provepharm Life Solutions raises €120 million appeared first on Pharma Mirror Magazine. This includes.
Deep Dive: Patients and Partnerships 2022
pharmaphorum
OCTOBER 27, 2022
pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector. Read Deep Dive: Patients and Partnerships 2022 in full. Subscribe to future issues of Deep Dive.
How to Leverage Omnichannel & Sales Enablement Technologies for Pharmaceutical Sales Success
Pharma Mirror
JUNE 23, 2023
In the fast-paced, highly competitive pharmaceutical industry, sales reps must adapt to new ways of engaging with customers and healthcare professionals (HCPs).
Indonesian pharmaceutical Bio Farma ready to produce IndoVac Covid-19 vaccines
Pharma Mirror
SEPTEMBER 11, 2022
Bandung, W Java, Indonesia, PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in the manufacturing of IndoVac, a Covid-19 vaccine brand it has developed since November 2021.
Vaccines 
52
52 
Pharmaceuticals and the environment: how can the industry put its best foot forward?
Pharma Mirror
NOVEMBER 26, 2021
There is a need for pharmaceutical companies to now make commitments on sustainable and ethical policies. Market-leading peptide oligonucleotide producer Bachem is keen to share how they are implementing sustainable practices and how the pharmaceutical industry at large can address their.
Two Immigrants, One Unique Plan For A Biopharma
Pharma Mirror
FEBRUARY 4, 2021
Create a pharmaceutical company that leverages the best of what the U.S. The post Two Immigrants, One Unique Plan For A Biopharma appeared first on Pharma Mirror Magazine. Their desire?
Telstar strengthens its activity in Bangladesh and relocates its office in Dhaka
Pharma Mirror
DECEMBER 10, 2020
The company, which has been active over the past 16 years. The post Telstar strengthens its activity in Bangladesh and relocates its office in Dhaka appeared first on Pharma Mirror Magazine. The new office is located in Green Rawshanara Tower (Level – 10) 755, Satmasjid Road, Dhanmondi C/A.
Almirall and Simcere enter into a licensing agreement for IL-2-mu-Fc
Pharma Mirror
OCTOBER 1, 2022
Nanjing (China) and Barcelona (Spain), a global biopharmaceutical company focused on skin health, and Simcere Pharmaceutical Group（2096.HK), The post Almirall and Simcere enter into a licensing agreement for IL-2-mu-Fc appeared first on Pharma Mirror Magazine.
The post-COVID face of pharma research and development
pharmaphorum
MARCH 5, 2021
The challenge posed by COVID was a trigger for pharmaceutical companies to think outside of the box. I believe all these adaptions would have come in the future, but they would have taken longer,” she says. • Read the full article in pharmaphorum’s Deep Dive digital magazine.
Deep Dive: Market Access
pharmaphorum
APRIL 30, 2021
pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector.
How biomarkers and bioanalytics are changing R&D
pharmaphorum
DECEMBER 1, 2021
Recent approvals in highly heterogenous tumours, such as non-small cell lung cancer, are now targeting smaller patient populations – representing just a single-digit percentage of patients with aggressive cancers and poor prognosis. The post How biomarkers and bioanalytics are changing R&D appeared first on.
The rise of the healthcare influencer
pharmaphorum
DECEMBER 19, 2022
There are numerous benefits for pharmaceutical companies in the healthcare influencer space. By listening to their conversations, pharmaceutical companies can leverage the patient perspective in the design, development, and promotion of their products and services, and build authentic one-to-one relationships.
Patients want to be heard. Is pharma listening?
pharmaphorum
NOVEMBER 22, 2021
A lot of pharmaceutical companies are trying to get their heads around how to include patients in the conversation,” says Natalie. Patients want to be part of the healthcare conversation and genuinely heard by those who make the final decisions, but pharma does not always understand how to connect with patients. “A Is pharma listening?
Leveraging real-world data to meet payers’ needs
pharmaphorum
NOVEMBER 26, 2021
But as healthcare costs continue to be squeezed, there is pressure on pharmaceutical companies to actually deliver on clinical trial efficacy in the real world. Certara’s Lee Stern and Shawn Bates discuss the challenges and how pharma can use real-world data to meet payers’ needs. For years, clinical trial data was king.
Country focus: China & APAC’s growing medical needs bring opportunities and challenges
pharmaphorum
JUNE 8, 2021
At the same time, lots of people with experience at multinational pharmaceutical companies have chosen to return home. All these factors will support the growth of in-house R&D-driven pharmaceutical companies and bring more innovative drugs to Asian markets.”. About the author. He can be contacted on LinkedIn.
Chemotherapy 105
105 
Refining digital collaboration
pharmaphorum
OCTOBER 11, 2021
Pharmaceutical companies are traditionally more conservative with their approach to and incorporation of new technologies; however, prior to COVID, the industry had begun moving toward intersecting health and technology. The post Refining digital collaboration appeared first on.
Deep Dive: Oncology 2022
pharmaphorum
JULY 7, 2022
pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector. ASCO 2022: Checkpoint inhibitors, Enhertu in spotlight. Read Deep Dive: Oncology in full.
Vaccines 52
52 
Deep Dive: Patients and Partnerships
pharmaphorum
DECEMBER 14, 2020
pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector. • Read the latest issue Deep Dive: Patients and Partnerships 2020 in full.
Deep Dive: Communications & Commercialisation 2022
pharmaphorum
SEPTEMBER 22, 2022
There is little doubt that the arrival of COVID-19 changed the game for communication and commercialisation efforts for pharmaceutical companies around the world. To make an impact with busy HCP’s, marketing teams must harness the power of effective communication, as Healthware MedComms explores in a new advertising campaign.
Deep Dive: Market Access
pharmaphorum
MAY 6, 2022
pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector. Read Deep Dive: Market Access in full. Subscribe to future issues of Deep Dive.
Deep Dive: Digital Health 2022
pharmaphorum
DECEMBER 2, 2022
Influencer culture has well and truly taken over the internet, with numerous benefits on offer for pharmaceutical companies in the healthcare influencer space. Company profile: Vinehealth. The rise of healthcare influencers and how to effectively engage with them. Read Deep Dive: Digital Health 2022 in full.
Effective Pharma Ad Types & Stats
Pharma Marketing Network
MARCH 23, 2023
Pharmaceutical advertising is a crucial aspect of promoting and marketing drugs to the public. With the increase in competition, it has become essential for pharmaceutical companies to find the most effective methods of advertisement to reach their target audience. billion in the US alone.
How automatization keeps drug safety in war-torn Ukraine
pharmaphorum
MAY 26, 2022
Ukrainian pharmaceutical companies are struggling to perform their duties in pharmacovigilance as Russia launched a wide-scale war in Ukraine. Russia’s full-scale invasion of Ukraine has already affected the global pharmaceutical industry a lot. This platform made work easier for many pharmaceutical companies.
Deep Dive: Research and Development
pharmaphorum
FEBRUARY 24, 2022
pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector. Read Deep Dive: Research and Development in full. Subscribe to future issues of Deep Dive.
Deep Dive: Patients and Partnerships
pharmaphorum
OCTOBER 28, 2021
pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector. Read Deep Dive: Patients and Partnerships in full. Subscribe to future issues of Deep Dive.
Deep Dive: Communications and Commercialisation
pharmaphorum
OCTOBER 1, 2021
An innovative learning and development company delivering a ground-breaking pharma programme designed to achieve tangible patient-centric results. Read Deep Dive: Communications and Commercialisation in full. Subscribe to future issues of Deep Dive. The post Deep Dive: Communications and Commercialisation appeared first on.
Deep Dive: Communications 2020
pharmaphorum
SEPTEMBER 17, 2020
pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector.
Effective Pharma Ad Types & Stats
Pharma Marketing Network
MARCH 25, 2023
Pharmaceutical advertising is a crucial aspect of promoting and marketing drugs to the public. With the increase in competition, it has become essential for pharmaceutical companies to find the most effective methods of advertisement to reach their target audience. billion in the US alone.
How will NICE fare in a post-Brexit world?
pharmaphorum
MAY 14, 2021
This article appears in our digital magazine, Deep Dive: Market Access 2021. Practically though, there are risks of additional processes and requirements (and expense) for pharmaceutical companies. NICE has a global reputation as a pioneering HTA – but is that influence at risk now that the UK has left the EU?
Deep Dive: Research and Development
pharmaphorum
FEBRUARY 26, 2021
pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector.
Vaccines 59
59 
Let's personalize your content